The global sales of the MicroRNA Market in 2023 were held at US$ 1.2 Bn. With a CAGR of 29.4% from 2023 to 2033, the market is projected to reach a valuation of US$ 15.5 Billion by 2033.
microRNA Consumables are expected to be the highest revenue-generating segment, which is projected to grow at a CAGR of over 28.5% during 2023 – 2033.
As per the microRNA Market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 24.6% CAGR.
microRNAs are tiny non-coding RNA molecules found in a wide variety of animals, plants, and viruses. They play an important role in the control of gene expression through post-transcriptional and RNA silencing mechanisms. Due to their benefits in treating and detecting chronic illnesses including liver disease, coronary heart disease, and cancer, they are gaining significant traction in the healthcare business.
microRNA research is undergoing a technological revolution, resulting in significant breakthroughs in microRNA technology. Manufacturers and researchers are inspired to develop fresh solutions in the last several years due to the technical improvements in the essential phases of microRNA expression profiling, target gene identification, and validation. For example, HTG Molecular Diagnostics, Inc. recently announced the HTG EdgeSeq mouse microRNA whole transcriptome test, a complete panel for microRNA expression profiling that can be used in preclinical functional investigations and translational medicine.
In the coming years, the number of pharma and biotech firms is projected to increase significantly. The strong market growth can be attributed to an increase in research funding for new start-ups and middle-sized enterprises looking to create microRNA-based medicines.
Proteomics and genomics developments, as well as increased acceptance of innovative techniques that aid in the achievement of research goals, will fuel microRNA market growth in the Asia Pacific.
microRNA's clinical and preclinical research applications are expanding through investigations and clinical trials. In nearly all human health disorders, microRNAs can be useful as drug resistance modulators, biomarkers for pathogenic illnesses, or medications for medical intervention.
As a result, one of the significant factors driving the market expansion throughout the projected period is an increase in the number of clinical trials for assessing the usefulness of microRNA in the treatment of several chronic illnesses. According to the Future Medicine Journal, a medicinal trial for the clinical development of TargomiRs, a microRNA mimic-based therapy for patients with recurrent thoracic cancer was done in May 2016.
Due to these increasing numbers of clinical trials that specifically target chronic diseases, there is an absolute dollar growth opportunity of over US$ 14.3 Bn during the forecasted period.
microRNA is used to treat chronic conditions including cancer, cardiovascular disease, and renal disease. However, their safety and toxicity are still a point of contention. As a result, a number of businesses have discontinued their clinical studies for innovative microRNA-based therapies.
For example, MicroRNA Therapeutics, Inc., a clinical-stage pharmaceutical firm, stated in September 2016 that it was terminating the current Phase 1 research of MRX34, its experimental therapy for several tumors. Due to several immune-related serious adverse events (SAE) seen in patients who received MRX34 throughout the trial, the firm voluntarily terminated enrolment and dosing in the clinical research.
In 2022, North America accounted for the highest market share. The rising number of clinical trials is a primary growth driver to explore innovative treatments and diagnostics, particularly in the United States. Furthermore, the increased number of extended product releases throughout the area will aid the geographical growth of the global market for microRNA.
The market in Asia Pacific is expected to develop at a substantially faster rate. This is attributable to a bigger patient pool, more usage of microRNA treatments, and increased medical tourism in countries like India, Singapore, and China.
Factors driving market growth in the Rest of the World include rising healthcare expenditure, technological improvements, and increased market penetration by key competitors.
The United States is expected to have the highest market share of US$ 6.7 Bn by 2033. The rising number of clinical trials coupled with increased per capita expenditure leading to high healthcare spending is expected to drive the market demand in the United States.
The microRNA market in the U.K. is expected to reach a valuation of US$ 440 Million by 2033. With an absolute dollar opportunity of US$ 26.1% from 2023 to 2033, the market is projected to gross an absolute dollar opportunity of US$ 397 Million.
In Japan, the market is projected to reach US$ 1 Billion by 2033, growing at a CAGR of 35.5%. The market is expected to register an absolute dollar opportunity of US$ 915 Million.
The market in South Korea is expected to reach a valuation of US$ 245 Million by 2033. With a CAGR of 28.6% from 2023 to 2033, the market in the country is expected to garner an absolute dollar opportunity of US$ 225 Million.
The market for microRNA consumables is forecasted to grow at a CAGR of 28.5% from 2023 to 2033. In 2022, the consumables category led the market, accounting for over 60% of the total revenue. microRNA profiling requires several consumables, including qPCR primers, detection kits, and transfection reagents.
Consumables' increased adoption is due to the sector’s expansion as they are replaced on a frequent basis due to their non-durable nature. Thermo Fisher Scientific Inc., Miltenyi Biotec, and NanoString are among the leading manufacturers of consumables.
In terms of instruments, real-time PCR led the market in 2020, with approximately one-third of the total microRNA market size, since it is regarded as the gold standard for microRNA identification when compared to other methods. Because of its high sensitivity and enhanced sequence specificity, it is regularly utilized as a trustworthy approach for detecting microRNA expression. It is employed in a variety of microRNA research projects, including microRNA profiling, validation, quantification, and functional analysis.
Players in the market have introduced novel biologics as well as shifted their focus on building a well-developed global distribution network to gain a competitive edge among their peers. Lately, the focus has also shifted to inorganic growth, especially in developing nations, allowing regional players to expand at unprecedented rates.
In March 2021, Microarray-based profiling found blood microRNA as a possible biomarker for hepatic sinusoidal obstruction syndrome, according to researchers from Chinese institutions. Research has also led to the development of numerous computer methods for predicting the relationship between microRNA and its target microRNA.
Similarly, recent developments related to the companies in the microRNA Market have been tracked by the team at Transparency Market Research, which is available in the full report.
By Services
By Products
By Application
By End-Use
By Region
| Attribute | Detail |
|---|---|
| Global Market Size in 2023 | US$ 1.2 Billion |
| Global Market Forecast Value in 2033 | US$ 15.5 Billion |
| Global Market CAGR (2023-2033) | 29.4% |
| U.S. Market CAGR (2023-2033) | 30.5% |
| Key Companies Profiled |
|
The market was reported at US$ 937 million in 2022.
The market is estimated to be valued at US$ 1.2 billion in 2023.
The market is expected to reach a valuation of US$ 15.5 Billion by 2033.
The market registered a CAGR of 24.6% over the last 4 years.
The market is projected to witness a CAGR of 29.4% from 2023 to 2033.
microRNA consumables are expected to garner a significant value share by 2023.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global microRNA Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Services
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Services , 2018-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Services , 2023-2033
5.3.1. Specimen
5.3.1.1. Whole Blood
5.3.1.2. Serum
5.3.1.3. Plasma
5.3.1.4. FFPE
5.3.1.5. Fresh Frozen Tissue
5.3.1.6. Other Specimens
5.3.2. Service Type
5.3.2.1. Isolation & Purification
5.3.2.2. miRNA cDNA Synthesis
5.3.2.3. Profiling, Localization, & Quantification
5.3.2.4. Functional Analysis
5.4. Y-o-Y Growth Trend Analysis By Services , 2018-2022
5.5. Absolute $ Opportunity Analysis By Services , 2023-2033
6. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Products
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Products , 2018-2022
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Products , 2023-2033
6.3.1. Instruments
6.3.2. Consumables
6.4. Y-o-Y Growth Trend Analysis By Products , 2018-2022
6.5. Absolute $ Opportunity Analysis By Products , 2023-2033
7. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2018-2022
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2023-2033
7.3.1. Cancer
7.3.2. Infectious Diseases
7.3.3. Immunological Disorder
7.3.4. Cardiovascular Disease
7.3.5. Neurological Disease
7.3.6. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application, 2018-2022
7.5. Absolute $ Opportunity Analysis By Application, 2023-2033
8. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2018-2022
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2023-2033
8.3.1. Biotechnology & Pharmaceutical Companies
8.3.2. Academic & Government Research Institutes
8.3.3. Other End-user
8.4. Y-o-Y Growth Trend Analysis By End-use, 2018-2022
8.5. Absolute $ Opportunity Analysis By End-use, 2023-2033
9. Global microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. MEA
9.4. Market Attractiveness Analysis By Region
10. North America microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Services
10.2.3. By Products
10.2.4. By Application
10.2.5. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Services
10.3.3. By Products
10.3.4. By Application
10.3.5. By End-use
10.4. Key Takeaways
11. Latin America microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Services
11.2.3. By Products
11.2.4. By Application
11.2.5. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Services
11.3.3. By Products
11.3.4. By Application
11.3.5. By End-use
11.4. Key Takeaways
12. Europe microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. Russia
12.2.1.7. Rest of Europe
12.2.2. By Services
12.2.3. By Products
12.2.4. By Application
12.2.5. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Services
12.3.3. By Products
12.3.4. By Application
12.3.5. By End-use
12.4. Key Takeaways
13. Asia Pacific microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. India
13.2.1.4. South Korea
13.2.1.5. Australia
13.2.1.6. Rest of APAC
13.2.2. By Services
13.2.3. By Products
13.2.4. By Application
13.2.5. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Services
13.3.3. By Products
13.3.4. By Application
13.3.5. By End-use
13.4. Key Takeaways
14. MEA microRNA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. Saudi Arabia
14.2.1.3. UAE
14.2.1.4. Israel
14.2.1.5. Rest of MEA
14.2.2. By Services
14.2.3. By Products
14.2.4. By Application
14.2.5. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Services
14.3.3. By Products
14.3.4. By Application
14.3.5. By End-use
14.4. Key Takeaways
15. Key Countries microRNA Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Services
15.1.2.2. By Products
15.1.2.3. By Application
15.1.2.4. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Services
15.2.2.2. By Products
15.2.2.3. By Application
15.2.2.4. By End-use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Services
15.3.2.2. By Products
15.3.2.3. By Application
15.3.2.4. By End-use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Services
15.4.2.2. By Products
15.4.2.3. By Application
15.4.2.4. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Services
15.5.2.2. By Products
15.5.2.3. By Application
15.5.2.4. By End-use
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Services
15.6.2.2. By Products
15.6.2.3. By Application
15.6.2.4. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Services
15.7.2.2. By Products
15.7.2.3. By Application
15.7.2.4. By End-use
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Services
15.8.2.2. By Products
15.8.2.3. By Application
15.8.2.4. By End-use
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Services
15.9.2.2. By Products
15.9.2.3. By Application
15.9.2.4. By End-use
15.10. Russia
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Services
15.10.2.2. By Products
15.10.2.3. By Application
15.10.2.4. By End-use
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Services
15.11.2.2. By Products
15.11.2.3. By Application
15.11.2.4. By End-use
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Services
15.12.2.2. By Products
15.12.2.3. By Application
15.12.2.4. By End-use
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Services
15.13.2.2. By Products
15.13.2.3. By Application
15.13.2.4. By End-use
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Services
15.14.2.2. By Products
15.14.2.3. By Application
15.14.2.4. By End-use
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Services
15.15.2.2. By Products
15.15.2.3. By Application
15.15.2.4. By End-use
15.16. South Africa
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Services
15.16.2.2. By Products
15.16.2.3. By Application
15.16.2.4. By End-use
15.17. Saudi Arabia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Services
15.17.2.2. By Products
15.17.2.3. By Application
15.17.2.4. By End-use
15.18. UAE
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Services
15.18.2.2. By Products
15.18.2.3. By Application
15.18.2.4. By End-use
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Services
15.19.2.2. By Products
15.19.2.3. By Application
15.19.2.4. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Services
16.3.3. By Products
16.3.4. By Application
16.3.5. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Merck KGaA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Thermo Fisher Scientific, Inc
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Horizon Discovery Ltd.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Synlogic
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. QIAGEN
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. GeneCopoeia Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. New England Biolabs
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Quantabio
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. NanoString
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. BioGenex
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. SeqMatic LLC
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Miltenyi Biotec
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodolog
List of Tables
Table 1: Global microRNA Market Value (US$ Mn) Forecast by Region, 2018-2033
Table 2: Global microRNA Market Value (US$ Mn) Forecast by Services , 2018-2033
Table 3: Global microRNA Market Value (US$ Mn) Forecast by Products , 2018-2033
Table 4: Global microRNA Market Value (US$ Mn) Forecast by Application, 2018-2033
Table 5: Global microRNA Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 6: North America microRNA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 7: North America microRNA Market Value (US$ Mn) Forecast by Services , 2018-2033
Table 8: North America microRNA Market Value (US$ Mn) Forecast by Products , 2018-2033
Table 9: North America microRNA Market Value (US$ Mn) Forecast by Application, 2018-2033
Table 10: North America microRNA Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 11: Latin America microRNA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 12: Latin America microRNA Market Value (US$ Mn) Forecast by Services , 2018-2033
Table 13: Latin America microRNA Market Value (US$ Mn) Forecast by Products , 2018-2033
Table 14: Latin America microRNA Market Value (US$ Mn) Forecast by Application, 2018-2033
Table 15: Latin America microRNA Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 16: Europe microRNA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 17: Europe microRNA Market Value (US$ Mn) Forecast by Services , 2018-2033
Table 18: Europe microRNA Market Value (US$ Mn) Forecast by Products , 2018-2033
Table 19: Europe microRNA Market Value (US$ Mn) Forecast by Application, 2018-2033
Table 20: Europe microRNA Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 21: Asia Pacific microRNA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 22: Asia Pacific microRNA Market Value (US$ Mn) Forecast by Services , 2018-2033
Table 23: Asia Pacific microRNA Market Value (US$ Mn) Forecast by Products , 2018-2033
Table 24: Asia Pacific microRNA Market Value (US$ Mn) Forecast by Application, 2018-2033
Table 25: Asia Pacific microRNA Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 26: MEA microRNA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 27: MEA microRNA Market Value (US$ Mn) Forecast by Services , 2018-2033
Table 28: MEA microRNA Market Value (US$ Mn) Forecast by Products , 2018-2033
Table 29: MEA microRNA Market Value (US$ Mn) Forecast by Application, 2018-2033
Table 30: MEA microRNA Market Value (US$ Mn) Forecast by End-use, 2018-2033
List of Figures
Figure 1: Global microRNA Market Value (US$ Mn) by Services , 2023-2033
Figure 2: Global microRNA Market Value (US$ Mn) by Products , 2023-2033
Figure 3: Global microRNA Market Value (US$ Mn) by Application, 2023-2033
Figure 4: Global microRNA Market Value (US$ Mn) by End-use, 2023-2033
Figure 5: Global microRNA Market Value (US$ Mn) by Region, 2023-2033
Figure 6: Global microRNA Market Value (US$ Mn) Analysis by Region, 2018-2033
Figure 7: Global microRNA Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 8: Global microRNA Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 9: Global microRNA Market Value (US$ Mn) Analysis by Services , 2018-2033
Figure 10: Global microRNA Market Value Share (%) and BPS Analysis by Services , 2023-2033
Figure 11: Global microRNA Market Y-o-Y Growth (%) Projections by Services , 2023-2033
Figure 12: Global microRNA Market Value (US$ Mn) Analysis by Products , 2018-2033
Figure 13: Global microRNA Market Value Share (%) and BPS Analysis by Products , 2023-2033
Figure 14: Global microRNA Market Y-o-Y Growth (%) Projections by Products , 2023-2033
Figure 15: Global microRNA Market Value (US$ Mn) Analysis by Application, 2018-2033
Figure 16: Global microRNA Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 17: Global microRNA Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 18: Global microRNA Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 19: Global microRNA Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 20: Global microRNA Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 21: Global microRNA Market Attractiveness by Services , 2023-2033
Figure 22: Global microRNA Market Attractiveness by Products , 2023-2033
Figure 23: Global microRNA Market Attractiveness by Application, 2023-2033
Figure 24: Global microRNA Market Attractiveness by End-use, 2023-2033
Figure 25: Global microRNA Market Attractiveness by Region, 2023-2033
Figure 26: North America microRNA Market Value (US$ Mn) by Services , 2023-2033
Figure 27: North America microRNA Market Value (US$ Mn) by Products , 2023-2033
Figure 28: North America microRNA Market Value (US$ Mn) by Application, 2023-2033
Figure 29: North America microRNA Market Value (US$ Mn) by End-use, 2023-2033
Figure 30: North America microRNA Market Value (US$ Mn) by Country, 2023-2033
Figure 31: North America microRNA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 32: North America microRNA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 33: North America microRNA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 34: North America microRNA Market Value (US$ Mn) Analysis by Services , 2018-2033
Figure 35: North America microRNA Market Value Share (%) and BPS Analysis by Services , 2023-2033
Figure 36: North America microRNA Market Y-o-Y Growth (%) Projections by Services , 2023-2033
Figure 37: North America microRNA Market Value (US$ Mn) Analysis by Products , 2018-2033
Figure 38: North America microRNA Market Value Share (%) and BPS Analysis by Products , 2023-2033
Figure 39: North America microRNA Market Y-o-Y Growth (%) Projections by Products , 2023-2033
Figure 40: North America microRNA Market Value (US$ Mn) Analysis by Application, 2018-2033
Figure 41: North America microRNA Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 42: North America microRNA Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 43: North America microRNA Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 44: North America microRNA Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 45: North America microRNA Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 46: North America microRNA Market Attractiveness by Services , 2023-2033
Figure 47: North America microRNA Market Attractiveness by Products , 2023-2033
Figure 48: North America microRNA Market Attractiveness by Application, 2023-2033
Figure 49: North America microRNA Market Attractiveness by End-use, 2023-2033
Figure 50: North America microRNA Market Attractiveness by Country, 2023-2033
Figure 51: Latin America microRNA Market Value (US$ Mn) by Services , 2023-2033
Figure 52: Latin America microRNA Market Value (US$ Mn) by Products , 2023-2033
Figure 53: Latin America microRNA Market Value (US$ Mn) by Application, 2023-2033
Figure 54: Latin America microRNA Market Value (US$ Mn) by End-use, 2023-2033
Figure 55: Latin America microRNA Market Value (US$ Mn) by Country, 2023-2033
Figure 56: Latin America microRNA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 57: Latin America microRNA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 58: Latin America microRNA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 59: Latin America microRNA Market Value (US$ Mn) Analysis by Services , 2018-2033
Figure 60: Latin America microRNA Market Value Share (%) and BPS Analysis by Services , 2023-2033
Figure 61: Latin America microRNA Market Y-o-Y Growth (%) Projections by Services , 2023-2033
Figure 62: Latin America microRNA Market Value (US$ Mn) Analysis by Products , 2018-2033
Figure 63: Latin America microRNA Market Value Share (%) and BPS Analysis by Products , 2023-2033
Figure 64: Latin America microRNA Market Y-o-Y Growth (%) Projections by Products , 2023-2033
Figure 65: Latin America microRNA Market Value (US$ Mn) Analysis by Application, 2018-2033
Figure 66: Latin America microRNA Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 67: Latin America microRNA Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 68: Latin America microRNA Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 69: Latin America microRNA Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 70: Latin America microRNA Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 71: Latin America microRNA Market Attractiveness by Services , 2023-2033
Figure 72: Latin America microRNA Market Attractiveness by Products , 2023-2033
Figure 73: Latin America microRNA Market Attractiveness by Application, 2023-2033
Figure 74: Latin America microRNA Market Attractiveness by End-use, 2023-2033
Figure 75: Latin America microRNA Market Attractiveness by Country, 2023-2033
Figure 76: Europe microRNA Market Value (US$ Mn) by Services , 2023-2033
Figure 77: Europe microRNA Market Value (US$ Mn) by Products , 2023-2033
Figure 78: Europe microRNA Market Value (US$ Mn) by Application, 2023-2033
Figure 79: Europe microRNA Market Value (US$ Mn) by End-use, 2023-2033
Figure 80: Europe microRNA Market Value (US$ Mn) by Country, 2023-2033
Figure 81: Europe microRNA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 82: Europe microRNA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 83: Europe microRNA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 84: Europe microRNA Market Value (US$ Mn) Analysis by Services , 2018-2033
Figure 85: Europe microRNA Market Value Share (%) and BPS Analysis by Services , 2023-2033
Figure 86: Europe microRNA Market Y-o-Y Growth (%) Projections by Services , 2023-2033
Figure 87: Europe microRNA Market Value (US$ Mn) Analysis by Products , 2018-2033
Figure 88: Europe microRNA Market Value Share (%) and BPS Analysis by Products , 2023-2033
Figure 89: Europe microRNA Market Y-o-Y Growth (%) Projections by Products , 2023-2033
Figure 90: Europe microRNA Market Value (US$ Mn) Analysis by Application, 2018-2033
Figure 91: Europe microRNA Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 92: Europe microRNA Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 93: Europe microRNA Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 94: Europe microRNA Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 95: Europe microRNA Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 96: Europe microRNA Market Attractiveness by Services , 2023-2033
Figure 97: Europe microRNA Market Attractiveness by Products , 2023-2033
Figure 98: Europe microRNA Market Attractiveness by Application, 2023-2033
Figure 99: Europe microRNA Market Attractiveness by End-use, 2023-2033
Figure 100: Europe microRNA Market Attractiveness by Country, 2023-2033
Figure 101: Asia Pacific microRNA Market Value (US$ Mn) by Services , 2023-2033
Figure 102: Asia Pacific microRNA Market Value (US$ Mn) by Products , 2023-2033
Figure 103: Asia Pacific microRNA Market Value (US$ Mn) by Application, 2023-2033
Figure 104: Asia Pacific microRNA Market Value (US$ Mn) by End-use, 2023-2033
Figure 105: Asia Pacific microRNA Market Value (US$ Mn) by Country, 2023-2033
Figure 106: Asia Pacific microRNA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 107: Asia Pacific microRNA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 108: Asia Pacific microRNA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 109: Asia Pacific microRNA Market Value (US$ Mn) Analysis by Services , 2018-2033
Figure 110: Asia Pacific microRNA Market Value Share (%) and BPS Analysis by Services , 2023-2033
Figure 111: Asia Pacific microRNA Market Y-o-Y Growth (%) Projections by Services , 2023-2033
Figure 112: Asia Pacific microRNA Market Value (US$ Mn) Analysis by Products , 2018-2033
Figure 113: Asia Pacific microRNA Market Value Share (%) and BPS Analysis by Products , 2023-2033
Figure 114: Asia Pacific microRNA Market Y-o-Y Growth (%) Projections by Products , 2023-2033
Figure 115: Asia Pacific microRNA Market Value (US$ Mn) Analysis by Application, 2018-2033
Figure 116: Asia Pacific microRNA Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 117: Asia Pacific microRNA Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 118: Asia Pacific microRNA Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 119: Asia Pacific microRNA Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 120: Asia Pacific microRNA Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 121: Asia Pacific microRNA Market Attractiveness by Services , 2023-2033
Figure 122: Asia Pacific microRNA Market Attractiveness by Products , 2023-2033
Figure 123: Asia Pacific microRNA Market Attractiveness by Application, 2023-2033
Figure 124: Asia Pacific microRNA Market Attractiveness by End-use, 2023-2033
Figure 125: Asia Pacific microRNA Market Attractiveness by Country, 2023-2033
Figure 126: MEA microRNA Market Value (US$ Mn) by Services , 2023-2033
Figure 127: MEA microRNA Market Value (US$ Mn) by Products , 2023-2033
Figure 128: MEA microRNA Market Value (US$ Mn) by Application, 2023-2033
Figure 129: MEA microRNA Market Value (US$ Mn) by End-use, 2023-2033
Figure 130: MEA microRNA Market Value (US$ Mn) by Country, 2023-2033
Figure 131: MEA microRNA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 132: MEA microRNA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 133: MEA microRNA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 134: MEA microRNA Market Value (US$ Mn) Analysis by Services , 2018-2033
Figure 135: MEA microRNA Market Value Share (%) and BPS Analysis by Services , 2023-2033
Figure 136: MEA microRNA Market Y-o-Y Growth (%) Projections by Services , 2023-2033
Figure 137: MEA microRNA Market Value (US$ Mn) Analysis by Products , 2018-2033
Figure 138: MEA microRNA Market Value Share (%) and BPS Analysis by Products , 2023-2033
Figure 139: MEA microRNA Market Y-o-Y Growth (%) Projections by Products , 2023-2033
Figure 140: MEA microRNA Market Value (US$ Mn) Analysis by Application, 2018-2033
Figure 141: MEA microRNA Market Value Share (%) and BPS Analysis by Application, 2023-2033
Figure 142: MEA microRNA Market Y-o-Y Growth (%) Projections by Application, 2023-2033
Figure 143: MEA microRNA Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 144: MEA microRNA Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 145: MEA microRNA Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 146: MEA microRNA Market Attractiveness by Services , 2023-2033
Figure 147: MEA microRNA Market Attractiveness by Products , 2023-2033
Figure 148: MEA microRNA Market Attractiveness by Application, 2023-2033
Figure 149: MEA microRNA Market Attractiveness by End-use, 2023-2033
Figure 150: MEA microRNA Market Attractiveness by Country, 2023-2033
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
MicroRNA Market
